Literature DB >> 29695547

An Improved In Vivo Methodology to Visualise Tumour Induced Changes in Vasculature Using the Chick Chorionic Allantoic Membrane Assay.

Naside Mangir1,2, Ahtasham Raza1, John W Haycock1, Christopher Chapple2, Sheila Macneil3.   

Abstract

BACKGROUND/AIM: Decreasing the vascularity of a tumour has proven to be an effective strategy to suppress tumour growth and metastasis. Anti-angiogenic therapies have revolutionized the treatment of advanced-stage cancers, however there is still demand for further improvement. This necessitates new experimental models that will allow researchers to reliably study aspects of angiogenesis. The aim of this study was to demonstrate an in vivo technique in which the highly vascular and accessible chorioallantoic membrane (CAM) of the chick embryo is used to study tumour-induced changes in the macro and microvessels.
MATERIALS AND METHODS: Two cancer cell lines (human melanoma (C8161) and human prostate cancer (PC3)) were selected as model cells. Human dermal fibroblasts were used as a control. One million cells were labelled with green fluorescent protein and implanted on the CAM of the chick embryo at embryonic development day (EDD) 7 and angiogenesis was evaluated at EDDs 10, 12 and 14. A fluorescently-tagged lectin (lens culinaris agglutinin (LCA)) was injected intravenously into the chick embryo to label endothelial cells. The LCA is known to label the luminal surface of endothelial cells, or dextrans, in the CAM vasculature. Macrovessels were imaged by a hand-held digital microscope and images were processed for quantification. Microvessels were evaluated by confocal microscopy. Tumour invasion was assessed by histological and optical sectioning.
RESULTS: Tumour cells (C8161 and PC3) produced quantifiable increases in the total area covered by blood vessels, compared to fibroblasts when assessed by digital microscopy. Tumour invasion could be demonstrated by both histological and optical sectioning. The most significant changes in tumour vasculature observed were in the microvascular structures adjacent to the tumour cells, which showed an increase in the endothelial cell coverage. Additionally, tumour intravasation and tumour thrombus formation could be detected in the areas adjacent to tumour cells. The fragility of tumour blood vessels could be demonstrated when tumour cells seeded on a synthetic scaffold were grown on CAM.
CONCLUSION: We report on a modification to a well-studied CAM in vivo assay, which can be effectively used to study tumour induced changes in macro and microvasculature. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Angiogenesis; melanoma; prostate cancer; tumour intravasation; tumour thrombus

Mesh:

Year:  2018        PMID: 29695547      PMCID: PMC6000782          DOI: 10.21873/invivo.11262

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  48 in total

1.  Unexpected effect of matrix metalloproteinase down-regulation on vascular intravasation and metastasis of human fibrosarcoma cells selected in vivo for high rates of dissemination.

Authors:  Elena I Deryugina; Andries Zijlstra; Juneth J Partridge; Tatyana A Kupriyanova; Mark A Madsen; Thales Papagiannakopoulos; James P Quigley
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

2.  Evaluating Metformin as a Potential Chemosensitizing Agent when Combined with Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Cells.

Authors:  Michelle J Mayer; Laurence H Klotz; Vasundara Venkateswaran
Journal:  Anticancer Res       Date:  2017-12       Impact factor: 2.480

3.  Keratinocytes contract human dermal extracellular matrix and reduce soluble fibronectin production by fibroblasts in a skin composite model.

Authors:  D R Ralston; C Layton; A J Dalley; S G Boyce; E Freedlander; S MacNeil
Journal:  Br J Plast Surg       Date:  1997-09

4.  Multi-parametric hydrogels support 3D in vitro bioengineered microenvironment models of tumour angiogenesis.

Authors:  Laura J Bray; Marcus Binner; Anja Holzheu; Jens Friedrichs; Uwe Freudenberg; Dietmar W Hutmacher; Carsten Werner
Journal:  Biomaterials       Date:  2015-03-24       Impact factor: 12.479

5.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

Authors:  Herbert Hurwitz; Louis Fehrenbacher; William Novotny; Thomas Cartwright; John Hainsworth; William Heim; Jordan Berlin; Ari Baron; Susan Griffing; Eric Holmgren; Napoleone Ferrara; Gwen Fyfe; Beth Rogers; Robert Ross; Fairooz Kabbinavar
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

6.  Production of multiple cytokines by cultured human melanomas.

Authors:  J L Bennicelli; D Guerry
Journal:  Exp Dermatol       Date:  1993-08       Impact factor: 3.960

7.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

8.  Docetaxel based chemotherapy in the treatment of patients with castration resistant prostate cancer.

Authors:  N Mangir; L Türkeri
Journal:  Actas Urol Esp       Date:  2014-03-16       Impact factor: 0.994

Review 9.  Vasculogenensis, angiogenesis and special features of tumor blood vessels.

Authors:  Sachie Hiratsuka
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01

10.  Chick chorioallantoic membrane (CAM) assay as an in vivo model to study the effect of newly identified molecules on ovarian cancer invasion and metastasis.

Authors:  Noor A Lokman; Alison S F Elder; Carmela Ricciardelli; Martin K Oehler
Journal:  Int J Mol Sci       Date:  2012-08-10       Impact factor: 6.208

View more
  7 in total

1.  Patient-Derived In Vitro and In Vivo Models of Cancer.

Authors:  Sally E Claridge; Julie-Ann Cavallo; Benjamin D Hopkins
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

2.  Cold Atmospheric Plasma Reduces Vessel Density and Increases Vascular Permeability and Apoptotic Cell Death in Solid Tumors.

Authors:  Philipp Kugler; Sven Becker; Christian Welz; Nadine Wiesmann; Jonas Sax; Christoph R Buhr; Markus H Thoma; Juergen Brieger; Jonas Eckrich
Journal:  Cancers (Basel)       Date:  2022-05-14       Impact factor: 6.575

Review 3.  Implementation of the Chick Chorioallantoic Membrane (CAM) Model in Radiation Biology and Experimental Radiation Oncology Research.

Authors:  Nicole Dünker; Verena Jendrossek
Journal:  Cancers (Basel)       Date:  2019-10-07       Impact factor: 6.639

4.  Exploitation of the chick embryo chorioallantoic membrane (CAM) as a platform for anti-metastatic drug testing.

Authors:  P Pawlikowska; T Tayoun; M Oulhen; V Faugeroux; V Rouffiac; A Aberlenc; A L Pommier; A Honore; V Marty; O Bawa; L Lacroix; J Y Scoazec; A Chauchereau; C Laplace-Builhe; F Farace
Journal:  Sci Rep       Date:  2020-10-09       Impact factor: 4.379

Review 5.  Microvascular Experimentation in the Chick Chorioallantoic Membrane as a Model for Screening Angiogenic Agents including from Gene-Modified Cells.

Authors:  Donna C Kennedy; Barbara Coen; Antony M Wheatley; Karl J A McCullagh
Journal:  Int J Mol Sci       Date:  2021-12-31       Impact factor: 5.923

6.  Extending the Applicability of In Ovo and Ex Ovo Chicken Chorioallantoic Membrane Assays to Study Cytostatic Activity in Neuroblastoma Cells.

Authors:  Miguel Angel Merlos Rodrigo; Berta Casar; Hana Michalkova; Ana Maria Jimenez Jimenez; Zbynek Heger; Vojtech Adam
Journal:  Front Oncol       Date:  2021-09-01       Impact factor: 6.244

Review 7.  Understanding and Modeling Metastasis Biology to Improve Therapeutic Strategies for Combating Osteosarcoma Progression.

Authors:  Timothy M Fan; Ryan D Roberts; Michael M Lizardo
Journal:  Front Oncol       Date:  2020-01-31       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.